INSIGHTS ON DRUG DEVELOPMENT
-
Cross-Site Work Within Cambrex's Network
Matthew Zart, Group Leader of Analytical Development, on what happens when a method arrives from another site — inheriting Phase II work from High Point and getting it commercial-ready for the QC lab.
-
Validating Antibodies With Knock-Out Technologies
Watch to learn about how one company achieves antibody validation through knock-out (KO) technologies as well as the significance of gene KO technologies in the large-scale screening of antibodies.
-
Viral Gene Therapy: Reducing Costs To Improve Patient Access
Gene therapy is revolutionizing medicine with its potential to cure genetic disorders. As approvals rise, so do concerns about accessibility, with million-dollar price tags limiting patient access.
-
NGS Identification Of Internal Tandem Duplications In FLT3
Accurately identifying genetic duplications in leukemia requires more than conventional sequencing. See how advanced enrichment and analysis approaches enable deeper insight into variant structure.
-
Advancing Cell Culture Strategies To Accelerate Biologics Development5/5/2026
Integrated stable expression strategies accelerate biologics material generation, improving scalability, consistency, and early developability insights while reducing bottlenecks, variability, and risks in transitioning from discovery to manufacturing.
-
Patient-Centric Formulations In Pediatric Adherence11/13/2025
Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.
-
Simplify And Streamline Method Development With In Silico Modeling5/19/2026
Automated screening paired with in silico modeling can cut method development time while improving robustness. See how combining experimentation and simulation enables faster decision‑making.
-
Take Action On PFAS To Protect Your Critical Processes9/18/2025
PFAS restrictions are tightening, but a full ban could disrupt critical industries lacking alternatives, such as pharmaceutical manufacturing. Learn where PFAS use remains indispensable.
-
In Vitro Drug Screening On Cancer Cells10/29/2025
Explore a high-throughput assay combining stain-free imaging and multiplexed viability/toxicity measurements to evaluate drug effects on cancer cells, ideal for labs optimizing cell-based screening.
DRUG DEVELOPMENT SOLUTIONS
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
Leica M60 Routine Stereo Microscopes
Easily inspect, screen, observe or document. Handle your daily inspection or documentation, work confidently, and stay flexible in times of change. The modular stereo microscopes of the M series from Leica are the right choice for an abundant variety of tasks in life sciences and industrial applications.
The M50, M60, and M80 allow operators to see a large sample overview, work comfortably under the microscope, and capture images of important details easily.
-
Waters MaxPeak Premier Columns and Solutions dramatically reduce NSA with MaxPeak High Performance Surfaces, innovative technologies designed to reduce analyte loss due to analyte/surface interactions.
-
Decades of experience in production technologies, quality control and knowledge of the regulatory environment result in high-quality drug delivery devices that are fully optimized to perform as a system.
-
The most powerful and versatile rheometer for your laboratory.